Evidence map›Paper›PMID 32194406›Full record

ArticleFrontiers in pharmacology2020

MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI.

Xiaosong Wei, Beibei Wang, Qi Wang, Xiaoming Yang, Yang Yang, Zhiwei Fang, Chengzhi Yi, Lei Shi, Xin Fan, Jin Tao and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Frontiers in cellular and infection microbiology · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Xiaosong WeiDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Beibei WangDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qi WangCollege of Science, The Australian National University, Canberra, ACT, Australia.
Xiaoming YangDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yang YangDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhiwei FangDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chengzhi YiDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lei ShiDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xin FanDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jin TaoDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yufeng GuoDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Dongkui SongDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
First Affiliated Hospital of Zhengzhou University · CNAustralian National University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we found miR-362-5p was upregulated in bladder cancer tissues and we predicted that QKI is potential a target of miR-362-5p and MBNL1-AS1 might be able to directly target to miR-362-5p. We attempted to evaluate whether miR-362-5p could play its roles in bladder cancer through regulating QKI (quaking) and whether the expression and function of miR-362-5p could be mediated by lncRNA MBNL1-AS1. We performed the gain- and loss-function experiments to explore the association between miR-362-5p expression and bladder cancer proliferation.

Indexed as

bladder cancerlncRNA MBNL1-AS1MiR-362-5pproliferationQKI

Identifiers

PMID32194406
PMCPMC7063466
OpenAlexW3010357773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.